Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 425
Selected: 0
NCT IDTitle
NCT02580994Pembrolizumab in Untreated Extensive SCLC
NCT01522612Colorectal Cancer (CRC) Cetuximab Elderly Frail
NCT00003979CHS 828 in Treating Patients With Solid Tumors
NCT01402271Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
NCT00002851Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed
NCT00083096Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
NCT00002669Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00002903Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer
NCT00005053Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
NCT00006249Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
NCT01819285Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer
NCT00433589Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes
NCT02218801A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program
NCT00424164Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer
NCT00003304Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
NCT00066378Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer
NCT00002511Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer
NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
NCT00016887Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
NCT05512364Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT00010153ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
NCT03088059Biomarker-based Study in R/M SCCHN
NCT03482362Vinorelbine in Advanced BRAF-like Colon Cancer
NCT00953459Sunitinib Malate in Treating Patients With Small Cell Lung Cancer
NCT07711080Eortc MoBilE Device (EMBED)
NCT06978062Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment
NCT00003941Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer
NCT00002722High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
NCT00085228Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
NCT00003805Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
NCT00006356Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer
NCT03488810Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer
NCT01724333International Validation of the QLQ-OH17 for Oral Health
NCT03859453Follow-up in Early and Locally Advanced Breast Cancer Patients
NCT04127110Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients
NCT00002990Surgery and BCG in Treating Patients With Bladder Cancer
NCT04685616Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
NCT00003985KRN7000 in Treating Patients With Solid Tumors
NCT03609047Adjuvant Palbociclib in Elderly Patients With Breast Cancer
NCT00068744Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
NCT00036868Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT01924819Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
NCT00008034Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer
NCT03005015Lenvatinib in Second Line Endometrial Carcinoma
NCT00002549Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
NCT02205047Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma
NCT04218825REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)
NCT01101425Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT03517137Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study
NCT00379041Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma